speb/financial-data huggingface dataset:
Financial ratios for KSCP — quarterly report dated 2025-09-30
Total revenue: 3131000
Gross profit: -1570000
Operating income: -9508000
Net income: -9539000
Capital expenditures: 231000
Operating cash flow: -7870000
Depreciation & amortization: 642000
Net tangible assets: 23972000
Owner earnings: -9128000
Return on net tangible assets (%): -38.07775738361422
Buffett classification: The Gruesome
Stock price: 5.77
Shares outstanding: 16916595
Book value: 26897000
P/B ratio: 3.628982903297765
Market cap (USD): 97608753.14999999
Debt to equity: 0.2741569691787188
Current ratio: 3.621212121212121
Quick ratio: 3.3661616161616164
COGS to revenue (%): 150.14372404982436
R&D to revenue (%): 120.50463110827212
SG&A to revenue (%): 133.02459278185884
Free cash flow (dilution-adjusted): -8477000
Buyback yield (%): 0
Retained earnings: -215957000
Inventory turnover: 2.5858085808580857
Receivables turnover: 1.270698051948052
Capitalized R&D asset: 5880580
ROCI (R&D-adjusted, %): -21.09947327503308
Rosenberg metric: -0.3106241067174845
FCF margin (%): -270.7441711913127
Revenue growth (%): 13.895962168061113
Rule of 40 score: -256.8482090232516
Financial ratios for KSCP — annual report dated 2025-12-31
Total revenue: 11335000
Gross profit: -4775000
Operating income: -33880000
Net income: -33815000
Capital expenditures: 635000
Operating cash flow: -30345000
Depreciation & amortization: 2560000
Net tangible assets: 24920000
Owner earnings: -31890000
Return on net tangible assets (%): -127.96950240770467
Buffett classification: The Gruesome
Stock price: 3.71
Shares outstanding: 16916595
Book value: 27766000
P/B ratio: 2.260338811856227
Market cap (USD): 62760567.45
Debt to equity: 0.28019880429302024
Current ratio: 3.9919769906145928
Quick ratio: 3.640932485619134
Interest coverage ratio: -868.7179487179487
COGS to revenue (%): 142.12615791795324
R&D to revenue (%): 110.1543890604323
SG&A to revenue (%): 146.61667401852668
Free cash flow (dilution-adjusted): -32535000
Buyback yield (%): 0
Retained earnings: -227007000
Inventory turnover: 6.946959896507115
Receivables turnover: 5.142921960072595
Capitalized R&D asset: 19312700
ROCI (R&D-adjusted, %): -55.64131120281714
Rosenberg metric: -0.15238634754284094
FCF margin (%): -287.03131892368765
Revenue growth (%): 4.905136510874595
Rule of 40 score: -282.1261824128131
Financial ratios for KSCP — quarterly report dated 2025-12-31
Total revenue: 2538000
Gross profit: -1619000
Operating income: -11287000
Net income: -11050000
Capital expenditures: 223000
Operating cash flow: -10610000
Depreciation & amortization: 623000
Net tangible assets: 24920000
Owner earnings: -10650000
Return on net tangible assets (%): -42.736757624398074
Buffett classification: The Gruesome
Stock price: 3.71
Shares outstanding: 16916595
Book value: 27766000
P/B ratio: 2.260338811856227
Market cap (USD): 62760567.45
Debt to equity: 0.28019880429302024
Current ratio: 3.9919769906145928
Quick ratio: 3.640932485619134
COGS to revenue (%): 163.79038613081167
R&D to revenue (%): 176.8715524034673
SG&A to revenue (%): 204.05831363278173
Free cash flow (dilution-adjusted): -11205000
Buyback yield (%): 0
Retained earnings: -227007000
Inventory turnover: 1.7925830099180682
Receivables turnover: 1.1515426497277677
Capitalized R&D asset: 7709580
ROCI (R&D-adjusted, %): -24.20038786718216
Rosenberg metric: -0.012987012987012988
FCF margin (%): -441.48936170212767
Revenue growth (%): -18.939635899073778
Rule of 40 score: -460.42899760120144
Financial ratios for LKY.AX — annual report dated 2022-06-30
Total revenue: 28968.96551724138
Gross profit: 28968.96551724138
Operating income: -1897415.8620689656
Net income: -1899977.9310344828
Capital expenditures: 101291.03448275862
Depreciation & amortization: 47022.06896551725
Net tangible assets: 4539347.586206896
Owner earnings: -1954246.8965517243
Return on net tangible assets (%): -43.051272444741414
Buffett classification: The Gruesome
Stock price: 0.08275862068965517
Shares outstanding: 375003263
Book value: 4539347.586206896
P/B ratio: 6.836831110774844
Market cap (USD): 31034752.8
Debt to equity: 0.012304669636560262
Current ratio: 3.5303588313631726
Quick ratio: 3.5303588313631726
Interest coverage ratio: -740.5795423956931
COGS to revenue (%): 0
SG&A to revenue (%): 1793.4960123794788
Free cash flow (dilution-adjusted): -1939854.4827586208
Buyback yield (%): 0.6777718802587237
Retained earnings: -2268791.0344827585
Receivables turnover: 0.07242253865954941
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -41.61155142970404
FCF margin (%): -6696.3194857755025
Rule of 40 score: -6696.3194857755025
Financial ratios for LKY.AX — annual report dated 2023-06-30
Total revenue: 44066.225165562915
Gross profit: 44066.225165562915
Operating income: -992214.5695364239
Net income: -993564.9006622516
Capital expenditures: 0
Depreciation & amortization: 46007.94701986755
Net tangible assets: 4535700.662251656
Owner earnings: -947556.953642384
Return on net tangible assets (%): -20.891082198797235
Buffett classification: The Gruesome
Stock price: 0.039735099337748346
Shares outstanding: 375003263
Book value: 4535700.662251656
P/B ratio: 3.285223831302742
Market cap (USD): 14900791.907284768
Debt to equity: 0.004599857378723732
Current ratio: 7.235973370749619
Quick ratio: 7.235973370749619
Interest coverage ratio: -734.7935262383522
COGS to revenue (%): 0
SG&A to revenue (%): 1017.9290652239255
Free cash flow (dilution-adjusted): -937023.178807947
Buyback yield (%): 0.2608821744216841
Retained earnings: -3172205.298013245
Receivables turnover: 0.5306939537257842
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -21.875662514374554
FCF margin (%): -2126.3976555455365
Revenue growth (%): 52.11528744212885
Rule of 40 score: -2074.282368103408
Financial ratios for LKY.AX — annual report dated 2024-06-30
Total revenue: 21990.666666666668
Gross profit: 21990.666666666668
Operating income: -1422330.6666666667
Net income: -1422568.6666666667
Capital expenditures: 21344.666666666668
Depreciation & amortization: 39729.333333333336
Net tangible assets: 5637346.666666667
Owner earnings: -1404184.0000000002
Return on net tangible assets (%): -24.908597661784153
Buffett classification: The Gruesome
Stock price: 0.013333333333333334
Shares outstanding: 375003263
Book value: 5637346.666666667
P/B ratio: 0.8869498014432322
Market cap (USD): 5000043.506666667
Debt to equity: 0.00021345739485005945
Current ratio: 14.267909107084437
Quick ratio: 14.267909107084437
Interest coverage ratio: -5976.179271708684
COGS to revenue (%): 0
SG&A to revenue (%): 2579.955132480446
Free cash flow (dilution-adjusted): -1405739.3333333333
Buyback yield (%): 3.791753673354037
Retained earnings: -4615922.666666667
Receivables turnover: 0.22605847119615127
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -25.23049850875471
FCF margin (%): -6392.436185048202
Revenue growth (%): -50.09632301372607
Rule of 40 score: -6442.532508061928
Financial ratios for MVCT.L — annual report dated 2022-03-31
Total revenue: 24752631.57894737
Net income: 24217105.263157893
Capital expenditures: 0
Operating cash flow: -2106578.947368421
Net tangible assets: 141535526.31578946
Owner earnings: 24217105.263157893
Return on net tangible assets (%): 17.110266159695815
Buffett classification: The Gruesome
Stock price: 0
P/E ratio: 0
Shares outstanding: 316405543
Book value: 141535526.31578946
P/B ratio: 0
Market cap (USD): 0
Debt to equity: 0
Effective tax rate (%): 0
COGS to revenue (%): 0
SG&A to revenue (%): 2.158196895598554
Free cash flow (dilution-adjusted): -2106578.947368421
Capitalized R&D asset: 0
FCF margin (%): -8.510525196682968
Rule of 40 score: -8.510525196682968
Financial ratios for MVCT.L — annual report dated 2023-03-31
Total revenue: -8755555.555555554
Net income: -9333333.333333332
Capital expenditures: 0
Operating cash flow: -3479012.345679012
Net tangible assets: 136187654.32098764
Owner earnings: -9333333.333333332
Return on net tangible assets (%): -6.853288853433896
Buffett classification: The Gruesome
Stock price: 0
Shares outstanding: 316405543
Book value: 136187654.32098764
P/B ratio: 0
Market cap (USD): 0
Debt to equity: 0
Free cash flow (dilution-adjusted): -3479012.345679012
Receivables turnover: -3545.9999999999995
Capitalized R&D asset: 0
Revenue growth (%): -135.37222104094312
Rule of 40 score: -135.37222104094312
Financial ratios for MVCT.L — annual report dated 2024-03-31
Total revenue: -9544303.797468355
Net income: -10194936.708860759
Capital expenditures: 0
Net tangible assets: 148169620.25316456
Owner earnings: -10194936.708860759
Return on net tangible assets (%): -6.880585029131852
Buffett classification: The Gruesome
Stock price: 0
Shares outstanding: 316405543
Book value: 148169620.25316456
P/B ratio: 0
Market cap (USD): 0
Debt to equity: 0
Free cash flow (dilution-adjusted): -2710126.5822784808
Receivables turnover: -94.25000000000001
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for MVCT.L — quarterly report dated 2024-09-30
Capital expenditures: 0
Net tangible assets: 158492000
Buffett classification: The Gruesome
Stock price: 0
Shares outstanding: 316405543
Book value: 158492000
P/B ratio: 0
Market cap (USD): 0
Debt to equity: 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for MVCT.L — quarterly report dated 2025-03-31
Capital expenditures: 0
Net tangible assets: 153548051.94805196
Buffett classification: The Gruesome
Stock price: 0
Shares outstanding: 316405543
Book value: 153548051.94805196
P/B ratio: 0
Market cap (USD): 0
Debt to equity: 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for MVCT.L — annual report dated 2025-03-31
Total revenue: -8909090.909090908
Net income: -9750649.350649351
Capital expenditures: 0
Net tangible assets: 153548051.94805196
Owner earnings: -9750649.350649351
Return on net tangible assets (%): -6.350226672981933
Buffett classification: The Gruesome
Stock price: 0
Shares outstanding: 316405543
Book value: 153548051.94805196
P/B ratio: 0
Market cap (USD): 0
Debt to equity: 0
Free cash flow (dilution-adjusted): -1919480.5194805195
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for MVCT.L — quarterly report dated 2025-09-30
Capital expenditures: 0
Net tangible assets: 154850000
Buffett classification: The Gruesome
Stock price: 0.005
Shares outstanding: 316405543
Book value: 154850000.00000003
P/B ratio: 0.010216517371649981
Market cap (USD): 1582027.715
Debt to equity: 0
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for NEU — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 312.67
Shares outstanding: 9198019
Market cap (USD): 2875944600.73
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for NEU — annual report dated 2022-12-31
Total revenue: 2764799000
Gross profit: 640497000
Operating income: 355139000
Net income: 279538000
Capital expenditures: 0
Operating cash flow: 108620000
Depreciation & amortization: 82285000
Net tangible assets: 636338000
Owner earnings: 361823000
Return on net tangible assets (%): 56.860190653394895
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 291.73
P/E ratio: 9.599188957744564
Shares outstanding: 9198019
Book value: 762407000
P/B ratio: 3.519561183029537
Market cap (USD): 2683338082.8700004
Debt to equity: 1.4279866265656007
Current ratio: 2.8123650878653983
Quick ratio: 1.3228572709236188
Effective tax rate (%): 19.611542155785745
Interest coverage ratio: 10.08860292028862
COGS to revenue (%): 76.83386748910138
R&D to revenue (%): 5.072773825511366
SG&A to revenue (%): 5.248338125122296
Free cash flow (dilution-adjusted): 52451000
Buyback yield (%): 7.731787556866395
Retained earnings: 834402000
Inventory turnover: 3.3645220096201514
Receivables turnover: 6.093999894201352
Capitalized R&D asset: 140252000
ROCI (R&D-adjusted, %): 21.130554141274366
FCF margin (%): 1.8970999338469088
Rule of 40 score: 1.8970999338469088
Financial ratios for NEU — annual report dated 2023-12-31
Total revenue: 2698419000
Gross profit: 772513000
Operating income: 483045000
Net income: 388864000
Capital expenditures: 48293000
Operating cash flow: 576823000
Depreciation & amortization: 78010000
Net tangible assets: 952419000
Owner earnings: 418581000
Return on net tangible assets (%): 43.94924922749336
Capex to operating income (%): 9.997619269426245
Buffett classification: The Great
Stock price: 522.63
P/E ratio: 12.362061466142404
Shares outstanding: 9198019
Book value: 1077061000
P/B ratio: 4.4632204396686905
Market cap (USD): 4807160669.97
Debt to equity: 0.6811109120096261
Current ratio: 2.85467536604387
Quick ratio: 1.601849716061994
Effective tax rate (%): 20.47152948490885
Interest coverage ratio: 12.929816108568216
COGS to revenue (%): 71.37164391445509
R&D to revenue (%): 5.114031586643883
SG&A to revenue (%): 5.613286891324142
Free cash flow (dilution-adjusted): 528530000
Buyback yield (%): 0.891669801422874
Retained earnings: 1096002000
Inventory turnover: 4.221311870662862
Receivables turnover: 6.241298117955633
Capitalized R&D asset: 231966840
ROCI (R&D-adjusted, %): 24.270655083537918
Rosenberg metric: 0.9412771297379003
FCF margin (%): 19.586654259401524
Revenue growth (%): -2.400897859121043
Rule of 40 score: 17.185756400280482
Financial ratios for NEU — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 535.49
Shares outstanding: 9198019
Market cap (USD): 4925447194.31
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for NEU — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 515.03
Shares outstanding: 9198019
Market cap (USD): 4737255725.57
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for NEU — annual report dated 2024-12-31
Total revenue: 2786558000
Gross profit: 886346000
Operating income: 590036000
Net income: 462413000
Capital expenditures: 57319000
Operating cash flow: 519592000
Depreciation & amortization: 116957000
Net tangible assets: 711159000
Owner earnings: 522051000
Return on net tangible assets (%): 73.40847827279133
Capex to operating income (%): 9.71449199709848
Buffett classification: The Great
Stock price: 515.03
P/E ratio: 10.244642182572722
Shares outstanding: 9198019
Book value: 1461583000
P/B ratio: 3.241181462544378
Market cap (USD): 4737255725.57
Debt to equity: 0.724589024366047
Current ratio: 2.7493070353932674
Quick ratio: 1.3996256121854955
Effective tax rate (%): 20.83419647427612
Interest coverage ratio: 10.285465258166859
COGS to revenue (%): 68.19208500235774
R&D to revenue (%): 4.482160428743992
SG&A to revenue (%): 6.151388200066175
Free cash flow (dilution-adjusted): 462273000
Buyback yield (%): 0.6736811742659305
Retained earnings: 1428713000
Inventory turnover: 3.759624554336342
Receivables turnover: 7.046549500568972
Capitalized R&D asset: 263639820
ROCI (R&D-adjusted, %): 19.23181472144162
Rosenberg metric: 0.8248887665038623
FCF margin (%): 16.589390926009795
Revenue growth (%): 3.266320019240896
Rule of 40 score: 19.855710945250692
Financial ratios for NEU — quarterly report dated 2025-03-31
Total revenue: 700946000
Gross profit: 236023000
Operating income: 159869000
Net income: 125949000
Capital expenditures: 13016000
Operating cash flow: 120313000
Depreciation & amortization: 28778000
Net tangible assets: 775370000
Owner earnings: 141711000
Return on net tangible assets (%): 18.27656473683532
Capex to operating income (%): 8.141665989028517
Buffett classification: The Great
Stock price: 555.08
P/E ratio: 10.134332917530111
Shares outstanding: 9198019
Book value: 1519496000
P/B ratio: 3.360085440514487
Market cap (USD): 5105636386.52
Debt to equity: 0.7008626544591101
Current ratio: 2.8359473775857587
Quick ratio: 1.5999843535887064
Effective tax rate (%): 23.254708645872054
Interest coverage ratio: 14.941028037383177
COGS to revenue (%): 66.32793396352929
R&D to revenue (%): 4.733032216461753
SG&A to revenue (%): 6.13142809859818
Free cash flow (dilution-adjusted): 107297000
Buyback yield (%): 1.1176667447502033
Retained earnings: 1475600000
Inventory turnover: 0.9492893443509971
Receivables turnover: 1.5128211215594696
Capitalized R&D asset: 33176000
ROCI (R&D-adjusted, %): 6.341334119439054
FCF margin (%): 15.307455923851482
Rule of 40 score: 15.307455923851482
Financial ratios for NEU — quarterly report dated 2025-06-30
Total revenue: 698509000
Gross profit: 220954000
Operating income: 143152000
Net income: 111244000
Capital expenditures: 16279000
Operating cash flow: 161077000
Depreciation & amortization: 28492000
Net tangible assets: 873850000
Owner earnings: 123457000
Return on net tangible assets (%): 14.127939577730734
Capex to operating income (%): 11.3718285458813
Buffett classification: The Great
Stock price: 679.87
P/E ratio: 26.36442549961424
Shares outstanding: 9198019
Book value: 1611723000
P/B ratio: 3.8799825885279295
Market cap (USD): 6253457177.53
Debt to equity: 0.5698100728226873
Current ratio: 2.6557830438329453
Quick ratio: 1.4250358144809885
Effective tax rate (%): 24.676344726721197
Interest coverage ratio: 13.335072193758734
COGS to revenue (%): 68.36776619914704
R&D to revenue (%): 4.634729115873954
SG&A to revenue (%): 6.5035668831754485
Free cash flow (dilution-adjusted): 144798000
Buyback yield (%): 0.3222857281635765
Retained earnings: 1541506000
Inventory turnover: 0.9650519653470049
Receivables turnover: 1.5395528852193807
Capitalized R&D asset: 54601920
ROCI (R&D-adjusted, %): 5.397710560904023
Rosenberg metric: -0.45421388955871717
FCF margin (%): 20.72958258232893
Revenue growth (%): -0.34767300191455547
Rule of 40 score: 20.381909580414376
Financial ratios for NEU — quarterly report dated 2025-09-30
Total revenue: 690311000
Gross profit: 209644000
Operating income: 130676000
Net income: 100269000
Capital expenditures: 20344000
Operating cash flow: 142409000
Depreciation & amortization: 33101000
Net tangible assets: 958933000
Owner earnings: 113026000
Return on net tangible assets (%): 11.786642028170895
Capex to operating income (%): 15.568275735406656
Buffett classification: The Great
Stock price: 817.72
P/E ratio: 22.288151248673927
Shares outstanding: 9198019
Book value: 1690396000
P/B ratio: 4.449492365504888
Market cap (USD): 7521404096.68
Debt to equity: 0.5099041881310652
Current ratio: 2.682528313929552
Quick ratio: 1.4348201039253374
Effective tax rate (%): 26.060217242218435
Interest coverage ratio: 15.604967757344161
COGS to revenue (%): 69.63049987614278
R&D to revenue (%): 5.073655207580352
SG&A to revenue (%): 6.365826417368403
Free cash flow (dilution-adjusted): 122065000
Buyback yield (%): 0
Retained earnings: 1615940000
Inventory turnover: 0.938494790771778
Receivables turnover: 1.5732185629083684
Capitalized R&D asset: 67662660
ROCI (R&D-adjusted, %): 4.57138075484141
Rosenberg metric: -0.3493544202137518
FCF margin (%): 17.682609722284592
Revenue growth (%): -1.1736427161282104
Rule of 40 score: 16.508967006156382
Financial ratios for NEU — quarterly report dated 2025-12-31
Total revenue: 635403000
Gross profit: 190779000
Operating income: 110028000
Net income: 81285000
Capital expenditures: 27998000
Operating cash flow: 145168000
Depreciation & amortization: 32051000
Net tangible assets: 837087000
Owner earnings: 85338000
Return on net tangible assets (%): 10.194639266886238
Capex to operating income (%): 25.44625004544298
Buffett classification: The Good
Stock price: 681.27
P/E ratio: 14.964487874850446
Shares outstanding: 9198019
Book value: 1778243000
P/B ratio: 3.5238909441116877
Market cap (USD): 6266334404.13
Debt to equity: 0.5492472063716826
Current ratio: 2.52746262035542
Quick ratio: 1.3295562143584583
Effective tax rate (%): 28.163001979638008
Interest coverage ratio: 11.131930392553622
COGS to revenue (%): 69.97511815336094
R&D to revenue (%): 4.960159143095012
SG&A to revenue (%): 7.748468294924639
Free cash flow (dilution-adjusted): 117170000
Buyback yield (%): 0
Retained earnings: 1669034000
Inventory turnover: 0.885251972595703
Receivables turnover: 1.5053946607784232
Capitalized R&D asset: 65666500
ROCI (R&D-adjusted, %): 3.4590135513960383
Rosenberg metric: -0.5386306532663316
FCF margin (%): 18.440265469316326
Revenue growth (%): -7.954096052359009
Rule of 40 score: 10.486169416957317
Financial ratios for NEU — annual report dated 2025-12-31
Total revenue: 2725169000
Gross profit: 857400000
Operating income: 543725000
Net income: 418747000
Capital expenditures: 77637000
Operating cash flow: 568967000
Depreciation & amortization: 122422000
Net tangible assets: 837087000
Owner earnings: 463532000
Return on net tangible assets (%): 55.37441150083564
Capex to operating income (%): 14.278725458641778
Buffett classification: The Great
Stock price: 681.27
P/E ratio: 14.964487874850446
Shares outstanding: 9198019
Book value: 1778243000
P/B ratio: 3.5238909441116877
Market cap (USD): 6266334404.13
Debt to equity: 0.5492472063716826
Current ratio: 2.52746262035542
Quick ratio: 1.3295562143584583
Effective tax rate (%): 25.298718072220378
Interest coverage ratio: 13.698259138890988
COGS to revenue (%): 68.53773105447772
R&D to revenue (%): 4.847075539168396
SG&A to revenue (%): 6.663219785635313
Free cash flow (dilution-adjusted): 491330000
Buyback yield (%): 1.2322674632414663
Retained earnings: 1669034000
Inventory turnover: 3.71875155547857
Receivables turnover: 6.456461273111513
Capitalized R&D asset: 261312000
ROCI (R&D-adjusted, %): 16.318908173484186
Rosenberg metric: -0.23175711380486477
FCF margin (%): 18.02934056566767
Revenue growth (%): -2.203040453491368
Rule of 40 score: 15.826300112176302
Financial ratios for NIQ — quarterly report dated 2025-09-30
Total revenue: 1052600000
Gross profit: 585700000
Operating income: -31800000
Net income: -196900000
Capital expenditures: 7400000
Operating cash flow: 272200000
Depreciation & amortization: 166900000
Net tangible assets: -3700200000
Owner earnings: -37400000
Buffett classification: The Gruesome
Stock price: 15.7
Shares outstanding: 295136342
Book value: 1224200000
P/B ratio: 3.7850355900996564
Market cap (USD): 4633640569.4
Debt to equity: 3.1582257801012905
Current ratio: 0.9932551113609218
Quick ratio: 0.9932551113609218
Interest coverage ratio: -0.3925925925925926
COGS to revenue (%): 44.356830704921144
SG&A to revenue (%): 43.21679650389512
Free cash flow (dilution-adjusted): 173900000
Buyback yield (%): 0
Retained earnings: -2169800000
Receivables turnover: 1.3024003959415986
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -0.5883005883005883
FCF margin (%): 16.520995629868896
Revenue growth (%): 1.1337432744043043
Rule of 40 score: 17.6547389042732
Financial ratios for NIQ — annual report dated 2025-12-31
Total revenue: 4198400000
Gross profit: 2336300000
Operating income: 141800000
Net income: -345300000
Capital expenditures: 34700000
Operating cash flow: 298700000
Depreciation & amortization: 632500000
Net tangible assets: -3634700000
Owner earnings: 252500000
Capex to operating income (%): 24.47108603667137
Buffett classification: The Great
Stock price: 16.49
Shares outstanding: 295136342
Book value: 1225600000
P/B ratio: 3.97095159887402
Market cap (USD): 4866798279.58
Debt to equity: 3.1611455613577024
Current ratio: 1.033497256075832
Quick ratio: 1.033497256075832
Interest coverage ratio: 0.4304796599878567
COGS to revenue (%): 44.352610518292686
SG&A to revenue (%): 38.054973323170735
Free cash flow (dilution-adjusted): -25300000
Buyback yield (%): 0
Retained earnings: -2202000000
Receivables turnover: 5.2486560820102515
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.626460945748208
FCF margin (%): -0.602610518292683
Revenue growth (%): 5.6839349544379
Rule of 40 score: 5.081324436145217
Financial ratios for NIQ — quarterly report dated 2025-12-31
Total revenue: 1139100000
Gross profit: 623900000
Operating income: 116800000
Net income: -29700000
Capital expenditures: 15500000
Operating cash flow: 188700000
Depreciation & amortization: 163300000
Net tangible assets: -3634700000
Owner earnings: 118100000
Capex to operating income (%): 13.270547945205479
Buffett classification: The Great
Stock price: 16.49
Shares outstanding: 295136342
Book value: 1225600000
P/B ratio: 3.97095159887402
Market cap (USD): 4866798279.58
Debt to equity: 3.1611455613577024
Current ratio: 1.033497256075832
Quick ratio: 1.033497256075832
Effective tax rate (%): 221.22448979591834
Interest coverage ratio: 1.825
COGS to revenue (%): 45.22868931612677
SG&A to revenue (%): 32.30620665437626
Free cash flow (dilution-adjusted): 83100000
Buyback yield (%): 0
Retained earnings: -2202000000
Receivables turnover: 1.4240530066258281
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.1634036563003574
FCF margin (%): 7.295233078746379
Revenue growth (%): 8.217746532395973
Rule of 40 score: 15.512979611142352
Financial ratios for OCCI — annual report dated 2021-10-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 5.12
Shares outstanding: 29372401
Market cap (USD): 150386693.12
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for OCCI — annual report dated 2022-10-31
Total revenue: -9992134
Net income: -13201386
Capital expenditures: 0
Operating cash flow: -14596820
Net tangible assets: 94210001
Owner earnings: -13201386
Return on net tangible assets (%): -14.012722492169383
Buffett classification: The Gruesome
Stock price: 4.32
Shares outstanding: 29372401
Book value: 94210001
P/B ratio: 1.3468715738576418
Market cap (USD): 126888772.32000001
Debt to equity: 0
Free cash flow (dilution-adjusted): -14596820
Buyback yield (%): 16.79935869049316
Retained earnings: -15337011
Receivables turnover: -16.453563601095354
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for OCCI — annual report dated 2023-10-31
Total revenue: 1406512
Net income: -1888359
Capital expenditures: 0
Operating cash flow: -23675274
Net tangible assets: 120188987
Owner earnings: -1888359
Return on net tangible assets (%): -1.5711580962072675
Buffett classification: The Gruesome
Stock price: 3.56
Shares outstanding: 29372401
Book value: 120188987
P/B ratio: 0.8700110565038708
Market cap (USD): 104565747.56
Debt to equity: 0
COGS to revenue (%): 0
SG&A to revenue (%): 191.16090015584652
Free cash flow (dilution-adjusted): -23675274
Buyback yield (%): 0
Retained earnings: -42909917
Receivables turnover: 1.6881999848765459
Capitalized R&D asset: 0
FCF margin (%): -1683.2614296927436
Rule of 40 score: -1683.2614296927436
Financial ratios for OCCI — annual report dated 2024-10-31
Total revenue: 18685935
Net income: 15021613
Capital expenditures: 0
Operating cash flow: -30552018
Net tangible assets: 148606804
Owner earnings: 15021613
Return on net tangible assets (%): 10.108294233957148
Buffett classification: The Gruesome
Stock price: 4.85
P/E ratio: 9.483411991109076
Shares outstanding: 29372401
Book value: 148606804
P/B ratio: 0.9586111874796795
Market cap (USD): 142456144.85
Debt to equity: 0
COGS to revenue (%): 0
SG&A to revenue (%): 17.21996250120746
Free cash flow (dilution-adjusted): -30552018
Buyback yield (%): 2.906078922997052
Retained earnings: -45168936
Receivables turnover: 23.33166642318541
Capitalized R&D asset: 0
FCF margin (%): -163.5027522037297
Revenue growth (%): 1228.5300800846348
Rule of 40 score: 1065.0273278809052
Financial ratios for OCCI — quarterly report dated 2024-10-31
Capital expenditures: 0
Net tangible assets: 148606804
Buffett classification: The Gruesome
Stock price: 4.85
Shares outstanding: 29372401
Book value: 148606804
P/B ratio: 0.9586111874796795
Market cap (USD): 142456144.85
Debt to equity: 0
Buyback yield (%): 0
Retained earnings: -45168936
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for OCCI — quarterly report dated 2025-04-30
Capital expenditures: 0
Net tangible assets: 160302793
Buffett classification: The Gruesome
Stock price: 5.05
Shares outstanding: 29372401
Book value: 160302793
P/B ratio: 0.9253152878627636
Market cap (USD): 148330625.04999998
Debt to equity: 0
Buyback yield (%): 0
Retained earnings: -70308558
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for OCCI — quarterly report dated 2025-10-31
Capital expenditures: 0
Net tangible assets: 153023304
Buffett classification: The Gruesome
Stock price: 4.09
Shares outstanding: 29372401
Book value: 153023304
P/B ratio: 0.7850642153825146
Market cap (USD): 120133120.08999999
Debt to equity: 0
Buyback yield (%): 0
Retained earnings: -65829897
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for OCCI — annual report dated 2025-10-31
Total revenue: -5735626
Net income: -9912509
Capital expenditures: 0
Operating cash flow: -50322852
Net tangible assets: 153023304
Owner earnings: -9912509
Return on net tangible assets (%): -6.477777397879214
Buffett classification: The Gruesome
Stock price: 4.09
Shares outstanding: 29372401
Book value: 153023304
P/B ratio: 0.7850642153825146
Market cap (USD): 120133120.08999999
Debt to equity: 0
Free cash flow (dilution-adjusted): -50322852
Buyback yield (%): 0.6690919201947118
Retained earnings: -65829897
Receivables turnover: -13.572619194108682
Capitalized R&D asset: 0
Revenue growth (%): -130.69488361165764
Rule of 40 score: -130.69488361165764
Financial ratios for POLYMED.NS — annual report dated 2022-03-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 12.424106554134248
Shares outstanding: 101359490
Market cap (USD): 1259301104.0327048
Buyback yield (%): 0
Retained earnings: 52623130.68706317
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for POLYMED.NS — annual report dated 2023-03-31
Total revenue: 135037539.5858709
Gross profit: 73000816.07795373
Operating income: 26534713.763702802
Net income: 21837088.91595615
Capital expenditures: 29126321.5590743
Operating cash flow: 23270645.554202195
Depreciation & amortization: 6963069.427527406
Net tangible assets: 145127576.1266748
Owner earnings: -326163.2155907452
Return on net tangible assets (%): -0.22474241236279813
Capex to operating income (%): 109.7668579297682
Buffett classification: The Gruesome
Stock price: 11.545066991473814
P/E ratio: 53.587825134355
Shares outstanding: 101359490
Book value: 151233520.09744215
P/B ratio: 7.7377164898207775
Market cap (USD): 1170202102.27162
Debt to equity: 0.1200173449808445
Current ratio: 2.750359867249728
Quick ratio: 2.0389621503525714
Effective tax rate (%): 24.50989804262386
Interest coverage ratio: 25.50011120085215
COGS to revenue (%): 45.94035384395299
R&D to revenue (%): 1.6057699298124526
SG&A to revenue (%): 3.4352427105125822
Free cash flow (dilution-adjusted): -5873666.260657735
Buyback yield (%): 0
Retained earnings: 64281193.66626066
Inventory turnover: 2.440976675350867
Receivables turnover: 4.709037853817663
Capitalized R&D asset: 2168392.204628502
ROCI (R&D-adjusted, %): 17.647440071928
FCF margin (%): -4.349654384011231
Rule of 40 score: -4.349654384011231
Financial ratios for POLYMED.NS — annual report dated 2024-03-31
Total revenue: 163771879.1221969
Gross profit: 91303201.82276052
Operating income: 36293860.17508095
Net income: 30970104.32905624
Capital expenditures: 32989519.126993645
Operating cash flow: 31908166.446816165
Depreciation & amortization: 7665967.142343206
Net tangible assets: 169861841.9474757
Owner earnings: 5646552.344405804
Return on net tangible assets (%): 3.3242029402647226
Capex to operating income (%): 90.89559216862791
Buffett classification: The Gruesome
Stock price: 19.008037428023034
P/E ratio: 62.20983175047758
Shares outstanding: 101359490
Book value: 176286545.1492985
P/B ratio: 10.929052911971445
Market cap (USD): 1926644979.6053264
Debt to equity: 0.11829821159570043
Current ratio: 2.3962667817720456
Quick ratio: 1.766934954831009
Effective tax rate (%): 24.98318902277317
Interest coverage ratio: 28.292342064426876
COGS to revenue (%): 44.24976845100771
R&D to revenue (%): 1.42362083093742
SG&A to revenue (%): 3.465242608939325
Free cash flow (dilution-adjusted): -1311152.4163568774
Buyback yield (%): 0
Retained earnings: 87642619.01906703
Inventory turnover: 2.7340868043490847
Receivables turnover: 5.059271583040304
Capitalized R&D asset: 3784313.363502343
ROCI (R&D-adjusted, %): 20.11602538655219
Rosenberg metric: 8.44053290070854
FCF margin (%): -0.8005967956065112
Revenue growth (%): 21.278778941357817
Rule of 40 score: 20.478182145751305
Financial ratios for POLYMED.NS — quarterly report dated 2024-09-30
Capital expenditures: 0
Net tangible assets: 302929228.38031536
Buffett classification: The Gruesome
Stock price: 27.600215002388918
Shares outstanding: 101359490
Book value: 309515408.5045389
P/B ratio: 9.038463480862424
Market cap (USD): 2797543716.5324893
Debt to equity: 0.06198818877126714
Current ratio: 4.6140790825778275
Quick ratio: 3.966979420591878
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for POLYMED.NS — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 30.430936006527567
Shares outstanding: 101359490
Market cap (USD): 3084464153.8442707
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for POLYMED.NS — annual report dated 2025-03-31
Total revenue: 195210614.91699788
Gross profit: 130276934.76736028
Operating income: 43278454.5241992
Net income: 39578816.9277531
Capital expenditures: 38536941.78162263
Operating cash flow: 27244528.87537994
Depreciation & amortization: 9724362.871171381
Net tangible assets: 316864928.6883329
Owner earnings: 10766238.017301843
Return on net tangible assets (%): 3.3977373456471955
Capex to operating income (%): 89.04417268429641
Buffett classification: The Gruesome
Stock price: 26.156027541136655
P/E ratio: 66.98435723419873
Shares outstanding: 101359490
Book value: 323317500.58452183
P/B ratio: 8.199870428302093
Market cap (USD): 2651161611.9955654
Debt to equity: 0.06517270266868509
Current ratio: 5.1787050354270425
Quick ratio: 4.4072397163243195
Effective tax rate (%): 25.183225929919246
Interest coverage ratio: 30.85932563664402
COGS to revenue (%): 33.26339614126359
R&D to revenue (%): 1.4387618487996034
SG&A to revenue (%): 3.909855341101462
Free cash flow (dilution-adjusted): -11453787.70166004
Buyback yield (%): 0
Retained earnings: 118498597.14753331
Inventory turnover: 1.9450133013414799
Receivables turnover: 4.774597949746721
Capitalized R&D asset: 5086283.972649114
ROCI (R&D-adjusted, %): 13.029206410280029
Rosenberg metric: 16.71623002551228
FCF margin (%): -5.867400042016213
Revenue growth (%): 19.19666304331969
Rule of 40 score: 13.329263001303476
Financial ratios for POLYMED.NS — quarterly report dated 2025-03-31
Total revenue: 51534743.97942483
Gross profit: 34215875.613747954
Operating income: 11507107.785831189
Net income: 10735819.499649286
Capital expenditures: 0
Depreciation & amortization: 2474678.512976385
Net tangible assets: 316864928.6883329
Owner earnings: 13210498.012625672
Return on net tangible assets (%): 4.169125963959067
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 26.156027541136655
P/E ratio: 61.73635864691495
Shares outstanding: 101359490
Book value: 323317500.58452183
P/B ratio: 8.199870428302093
Market cap (USD): 2651161611.9955654
Debt to equity: 0.06517270266868509
Current ratio: 5.1787050354270425
Quick ratio: 4.4072397163243195
Effective tax rate (%): 25.246399650954178
Interest coverage ratio: 45.41678586259401
COGS to revenue (%): 33.60619851452334
R&D to revenue (%): 1.469279869119081
Buyback yield (%): 0
Retained earnings: 118498597.14753331
Inventory turnover: 0.5187666748257099
Receivables turnover: 1.2604728643957495
Capitalized R&D asset: 757189.6188917465
ROCI (R&D-adjusted, %): 3.6323265317665685
Rule of 40 score: 0
Financial ratios for POLYMED.NS — quarterly report dated 2025-06-30
Total revenue: 47181219.2838755
Gross profit: 32293517.43505734
Operating income: 9698244.79288556
Net income: 10891984.554177394
Capital expenditures: 0
Depreciation & amortization: 2721460.332319214
Owner earnings: 13613444.886496607
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 25.973554879475778
P/E ratio: 121.72600923878213
Shares outstanding: 101359490
Market cap (USD): 2632666276.0706763
Effective tax rate (%): 24.28979155940439
Interest coverage ratio: 28.094369682383643
COGS to revenue (%): 31.554296550165954
R&D to revenue (%): 1.6568260713319363
Buyback yield (%): 0
Capitalized R&D asset: 1289027.7865250106
ROCI (R&D-adjusted, %): 773.2175250234571
Rosenberg metric: -2.538806833490741
Revenue growth (%): -8.44774681967463
Rule of 40 score: -8.44774681967463
Financial ratios for POLYMED.NS — quarterly report dated 2025-09-30
Total revenue: 50043021.4205186
Gross profit: 34748996.61781285
Operating income: 10118804.96054115
Net income: 10353438.556933483
Capital expenditures: 0
Depreciation & amortization: 2810687.7113866964
Net tangible assets: 297061127.3957159
Owner earnings: 13164126.26832018
Return on net tangible assets (%): 4.431453682185826
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 21.962795941375422
P/E ratio: 69.60760789334975
Shares outstanding: 101359490
Book value: 330605366.40360767
P/B ratio: 6.733519845150313
Market cap (USD): 2226137795.5918827
Debt to equity: 0.08169049732007452
Current ratio: 3.8851641616580133
Quick ratio: 3.1937079429223987
Effective tax rate (%): 24.564653057803294
Interest coverage ratio: 30.192686783059173
COGS to revenue (%): 30.561753404511478
R&D to revenue (%): 1.7586897046419585
Buyback yield (%): 0
Inventory turnover: 0.3914836195482664
Receivables turnover: 1.0426099636210577
Capitalized R&D asset: 1653720.2368999592
ROCI (R&D-adjusted, %): 2.915731664961719
Rosenberg metric: 3.141160855598922
Revenue growth (%): 6.065553582717895
Rule of 40 score: 6.065553582717895
Financial ratios for POLYMED.NS — quarterly report dated 2025-12-31
Total revenue: 54991144.03475549
Gross profit: 20175793.69499833
Operating income: -8282232.371616353
Net income: 7901325.609891946
Capital expenditures: 0
Depreciation & amortization: 3203275.0362036317
Owner earnings: 11104600.646095578
Buffett classification: The Gruesome
Stock price: 19.75827113735101
P/E ratio: 50.2146269689468
Shares outstanding: 101359490
Market cap (USD): 2002688285.7636182
Effective tax rate (%): 27.45918811627609
Interest coverage ratio: -12.476439790575917
COGS to revenue (%): 63.31083113628836
R&D to revenue (%): 1.206955052663244
Buyback yield (%): 0
Capitalized R&D asset: 1511350.9182227605
ROCI (R&D-adjusted, %): -555.3766994333022
Rosenberg metric: -16.558548635798985
Revenue growth (%): 9.887737538181629
Rule of 40 score: 9.887737538181629
Financial ratios for RAJSREESUG.NS — annual report dated 2022-03-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 0.4292496373466965
Shares outstanding: 33135606
Market cap (USD): 14223446.85876302
Buyback yield (%): 0
Retained earnings: -13700461.558749836
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for RAJSREESUG.NS — annual report dated 2023-03-31
Total revenue: 93141364.19001219
Gross profit: 20841753.95858709
Operating income: 3397259.4397076736
Net income: -1092411.6930572474
Capital expenditures: 5692131.5468940325
Operating cash flow: 1893337.3934226555
Depreciation & amortization: 2948684.5310596833
Net tangible assets: 30591449.451887943
Owner earnings: -3835858.7088915966
Return on net tangible assets (%): -12.538989742621915
Capex to operating income (%): 167.55068748543465
Buffett classification: The Gruesome
Stock price: 0.4750304506699148
Shares outstanding: 33135606
Book value: 30620889.159561515
P/B ratio: 0.5140419590489166
Market cap (USD): 15740421.851400733
Debt to equity: 1.5943833968118217
Current ratio: 1.0870174944865203
Quick ratio: 0.3006828832708146
Effective tax rate (%): 143.25871690614343
Interest coverage ratio: 1.9851460131956353
COGS to revenue (%): 77.62352512244821
SG&A to revenue (%): 0.90747813560151
Free cash flow (dilution-adjusted): 1403032.8867235081
Buyback yield (%): 0
Retained earnings: -15916881.851400731
Inventory turnover: 3.993241665943472
Receivables turnover: 19.291174942103062
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 4.407096481622811
FCF margin (%): 1.5063477960890328
Rule of 40 score: 1.5063477960890328
Financial ratios for RAJSREESUG.NS — annual report dated 2024-03-31
Total revenue: 91333025.54263102
Gross profit: 22848830.79505936
Operating income: 4589986.8089699
Net income: 1649802.134548507
Capital expenditures: 387900.22784506535
Operating cash flow: 4623300.155893992
Depreciation & amortization: 2836527.1615301594
Net tangible assets: 31742055.402326416
Owner earnings: 4098429.068233601
Return on net tangible assets (%): 12.911668813775751
Capex to operating income (%): 8.451009643143598
Buffett classification: The Great
Stock price: 0.6969769673704415
P/E ratio: 13.998499394705918
Shares outstanding: 33135606
Book value: 31771039.693008758
P/B ratio: 0.7269121314573732
Market cap (USD): 23094754.181861803
Debt to equity: 1.4817038809354766
Current ratio: 0.9661683289843186
Quick ratio: 0.2146616460688745
Effective tax rate (%): 34.67534009164075
Interest coverage ratio: 1.6131178907530794
COGS to revenue (%): 74.98294766946668
SG&A to revenue (%): 0.8765455910715245
Free cash flow (dilution-adjusted): 4123611.9438781627
Buyback yield (%): 0
Retained earnings: -14046816.165007794
Inventory turnover: 3.327669802497982
Receivables turnover: 24.849138662316477
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 6.63013695782691
FCF margin (%): 4.514918803334076
Revenue growth (%): -1.9414989925336361
Rule of 40 score: 2.5734198108004405
Financial ratios for RAJSREESUG.NS — quarterly report dated 2024-09-30
Capital expenditures: 0
Net tangible assets: 33607823.69804109
Buffett classification: The Gruesome
Stock price: 0.903368370759675
Shares outstanding: 33135606
Book value: 33636693.74104156
P/B ratio: 0.8899108407266312
Market cap (USD): 29933658.406354513
Debt to equity: 1.3520466864389447
Current ratio: 1.0530635924251988
Quick ratio: 0.34771881823063866
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for RAJSREESUG.NS — annual report dated 2025-03-31
Total revenue: 74927320.55178863
Gross profit: 17925835.866261397
Operating income: 2878571.428571428
Net income: 945873.2756605096
Capital expenditures: 2052840.7762450315
Operating cash flow: 9696223.98877718
Depreciation & amortization: 2742108.9548749123
Net tangible assets: 30851227.495908346
Owner earnings: 1635141.4542903905
Return on net tangible assets (%): 5.3000855622592375
Capex to operating income (%): 71.31456790925668
Buffett classification: The Good
Stock price: 0.4474267709184269
P/E ratio: 15.674147453476078
Shares outstanding: 33135606
Book value: 30879483.282674767
P/B ratio: 0.4801167512839629
Market cap (USD): 14825757.195005253
Debt to equity: 1.13284655173654
Current ratio: 1.0448417596935948
Quick ratio: 0.26524451680490035
Effective tax rate (%): 26.94818386196809
Interest coverage ratio: 1.5451852781525524
COGS to revenue (%): 76.0757014474162
SG&A to revenue (%): 1.1060051490939002
Free cash flow (dilution-adjusted): 9169499.649286883
Buyback yield (%): 0
Retained earnings: -10809457.563712882
Inventory turnover: 4.173295194370908
Receivables turnover: 26.29708361028368
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 4.587395593448766
FCF margin (%): 12.237858743325893
Revenue growth (%): -17.962511253045903
Rule of 40 score: -5.724652509720011
Financial ratios for RAJSREESUG.NS — quarterly report dated 2025-03-31
Total revenue: 20404243.62871171
Gross profit: 8052419.920505026
Operating income: 2685258.3586626137
Net income: 1386544.3067570727
Capital expenditures: 0
Depreciation & amortization: 694084.6387654898
Net tangible assets: 30851227.495908346
Owner earnings: 2080628.9455225626
Return on net tangible assets (%): 6.744071838951974
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 0.4474267709184269
P/E ratio: 2.673148835337358
Shares outstanding: 33135606
Book value: 30879483.282674767
P/B ratio: 0.4801167512839629
Market cap (USD): 14825757.195005253
Debt to equity: 1.13284655173654
Current ratio: 1.0448417596935948
Quick ratio: 0.26524451680490035
Effective tax rate (%): 20.105488642793627
Interest coverage ratio: 2.530678124827852
COGS to revenue (%): 60.53556276315918
Buyback yield (%): 0
Retained earnings: -10809457.563712882
Inventory turnover: 0.904323927833825
Receivables turnover: 7.161234336919327
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 4.279324889955452
Rule of 40 score: 0
Financial ratios for RAJSREESUG.NS — quarterly report dated 2025-06-30
Total revenue: 16490603.791247368
Gross profit: 2752609.4079101337
Operating income: -1292054.7624619706
Net income: -1654797.5661128014
Capital expenditures: 0
Depreciation & amortization: 685104.1422887901
Owner earnings: -969693.4238240113
Buffett classification: The Gruesome
Stock price: 0.5727825883454248
Shares outstanding: 33135606
Market cap (USD): 18979498.17107419
Interest coverage ratio: -3.46401681515874
COGS to revenue (%): 83.30801320100164
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): -19.180519056130503
Rule of 40 score: -19.180519056130503
Financial ratios for RAJSREESUG.NS — quarterly report dated 2025-09-30
Total revenue: 13171183.765501691
Gross profit: 3830834.272829763
Operating income: -488872.6042841037
Net income: -809165.7271702368
Capital expenditures: 0
Depreciation & amortization: 672626.8320180383
Net tangible assets: 27348602.029312287
Owner earnings: -136538.8951521985
Return on net tangible assets (%): -0.49925365474204436
Buffett classification: The Gruesome
Stock price: 0.4430665163472378
Shares outstanding: 33135606
Book value: 27375851.1837655
P/B ratio: 0.5362857000837644
Market cap (USD): 14681277.51747463
Debt to equity: 1.3814984363147271
Current ratio: 1.0421778489175606
Quick ratio: 0.29849804918846395
Interest coverage ratio: -1.2792577514234298
COGS to revenue (%): 70.91503435808416
Buyback yield (%): 0
Inventory turnover: 0.9019638795957493
Receivables turnover: 5.543906270019408
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -0.8226588901437447
Revenue growth (%): -20.12916002206971
Rule of 40 score: -20.12916002206971
Financial ratios for RAJSREESUG.NS — quarterly report dated 2025-12-31
Total revenue: 10915461.735546397
Gross profit: 2361078.3112398353
Operating income: -1855664.4758828117
Net income: -1023582.4885819317
Capital expenditures: 0
Depreciation & amortization: 650841.0382087558
Owner earnings: -372741.4503731759
Buffett classification: The Gruesome
Stock price: 0.3942296981174112
Shares outstanding: 33135606
Market cap (USD): 13063039.95031748
Interest coverage ratio: -4.625763634344108
COGS to revenue (%): 78.36941424519917
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): -17.126190554440065
Rule of 40 score: -17.126190554440065
Financial ratios for RATNAVEER.NS — annual report dated 2024-03-31
Total revenue: 71393452.4523324
Gross profit: 9128432.665787265
Operating income: 5295479.074229524
Net income: 3723468.0417316225
Capital expenditures: 7900227.845065355
Operating cash flow: 1480992.9248111285
Depreciation & amortization: 698405.084542511
Net tangible assets: 30233121.47739537
Owner earnings: -3478354.718791222
Return on net tangible assets (%): -11.505112766446926
Capex to operating income (%): 149.18816096378995
Buffett classification: The Gruesome
Stock price: 1.3837571976967369
P/E ratio: 26.544388949656163
Shares outstanding: 71426681
Book value: 30233121.47739537
P/B ratio: 3.269169014361852
Market cap (USD): 98837183.94133876
Debt to equity: 0.8178284426886251
Current ratio: 1.7448646479061678
Quick ratio: 0.6525531820006244
Effective tax rate (%): 20.574015808456757
Interest coverage ratio: 4.515696901523673
COGS to revenue (%): 87.21390778533636
SG&A to revenue (%): 0.8897287309985723
Free cash flow (dilution-adjusted): -6434344.645640964
Buyback yield (%): 0
Retained earnings: 10171243.554383019
Inventory turnover: 2.119912301115834
Receivables turnover: 13.299452697419857
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 15.130303092599823
FCF margin (%): -9.012513647434282
Revenue growth (%): 22.18127793418152
Rule of 40 score: 13.168764286747237